Chronic hepatitis B virus infection is strongly associated with the development of hepatocellular carcinoma (HCC). Epithelial tumors are frequently characterized by loss of cadherin expression or function. Cadherindependent adhesion prevents the acquisition of a migratory and invasive phenotype, and loss of its function is itself enough for the progression from adenoma to carcinoma. The HBx protein of hepatitis B virus is thought to contribute to the development of the carcinoma, however, its role in the oncogenic and metastatic processes is far from being fully understood. We report herein the ability of HBx to disrupt intercellular adhesion in three dierent cell lines stably transfected with an inducible HBx expression vector. The linkage between the actin cytoskeleton and cadherin complex, which is essential for its function, is disrupted in the presence of HBx, as indicated by detergent solubility and immunoprecipitation experiments. In addition, b-catenin was tyrosine phosphorylated in HBx-expressing cells. Inhibition of the src family of tyrosine kinases resulted in the prevention of the disruption of adherens junctions. These results suggest that HBx is able to disrupt intercellular adhesion in a src-dependent manner, and provide a novel mechanism by which HBx may contribute to the development of HCC. Oncogene (2001) 20, 3323 ± 3331.
Introduction
The hepatitis B virus (HBV) causes acute and chronic hepatic injury (Chisari, 2000) , and its infection is strongly associated with the development of hepatocellular carcinoma (HCC) (Schafer and Sorrell, 1999) . The HBV genome is composed of a partially doublestranded circular DNA and contains four overlapping genes: S/preS, C/preC, P and X. The X gene encodes a 17 KDa protein, termed HBx, that is involved in dierent viral and cellular processes (Feitelson and Duan, 1997) . The X gene is the most frequently integrated viral sequence found in HCCs. In addition, dierent reports have described that HBx is expressed in most primary hepatic tumors, whereas other viral transcripts or proteins are not usually found, suggesting a possible role for HBx in the dierent steps of carcinoma development (Feitelson and Duan, 1997) . In this regard, in transgenic mice, HBx was shown to either induce HCC or to potentiate c-myc and chemical carcinogen-induced liver cancer (Kim et al., 1991; Slagle et al., 1996; Terradillos et al., 1997; Ueda et al., 1995; Yu et al., 1999) .
Dierent mechanisms have been proposed to explain the procarcinogenic activity of HBx. A variety of signaling pathways and transcription factors are known to be activated by this viral protein, thus contributing to the induction of a variety of cellular genes, including growth factors and proto-oncogenes (Feitelson and Duan, 1997; Haviv et al., 1998; KekuleÂ et al., 1993; Klein and Schneider, 1997; Lara-Pezzi et al., 1998; Maguire et al., 1991) . HBx is also capable of interfering with the DNA repair and apoptosis mechanisms and with normal p53 function (Gottlob et al., 1998a; Lee et al., 1995; Ueda et al., 1995) , favoring cell cycle progression and misregulated cell growth (Koike et al., 1994) . Although some of the signaling pathways triggered by HBx are known to be involved in the acquisition of metastasic properties, the possible contribution of this viral protein to the ®nal steps of tumor development remains far unknown.
In normal tissues, epithelial and endothelial cells are tightly associated with each other, and therefore, they are not allowed to migrate freely (Gumbiner, 1996) . Cell ± cell adhesion is achieved through dierent structures, such as adherens junctions, tight junctions and desmosomes. Adherens junctions are mediated by a family of transmembrane glycoproteins called cadherins, which exhibit calcium-dependent homophilic binding (Geiger and Ayalon, 1992; Gumbiner, 1996) . By regulating cell adhesion, cadherins play a critical role in dierent biological processes, including the regulation of epithelial cell polarization and dierentiation, tissue rearrangement and cell migration (Gumbiner, 1996) .
Anchorage of cadherins to the actin cytoskeleton is essential for their function, and is mediated by a complex of dierent proteins, including catenins, aactinin or vinculin (Provost and RimmoÈ , 1999; Tsukita et al., 1992) . The dynamic regulation of adherens junctions seems to be mediated by tyrosine phosphorylation of b-catenin, which appears to be a key step in the dissociation of the cadherin-cytoskeleton interaction that leads to adhesive instability (Provost and RimmoÈ , 1999) . Tyrosine phosphorylation of b-catenin results in an increase in its free cytosolic pool, and directly correlates with increased cell migration and loss of epithelial morphology (MuÈ ller et al., 1999) , suggesting that phosphorylation of b-catenin at the adherens junction provides a mechanism for regulating the cell's invasive behavior.
HCC has a poor prognosis due to multicentric development and intrahepatic metastasis (Schafer and Sorrell, 1999) . Disruption of intercellular adhesion is the ®rst step required for tumor spreading. Dierent reports have provided evidence that loss of cadherin expression or function leads to disruption of cell ± cell adhesion, epithelial to mesenchymal transition and acquisition of invasive and metastasic properties (Tlsty, 1998) . Re-establishment of the functional cadherin complex in tumor cell lines results in a reversion from an invasive to a benign epithelial phenotype (Vleminckx et al., 1991) . In vivo experiments showed that loss of E-cadherin-mediated cell adhesion results in the transition from adenoma to carcinoma (Perl et al., 1998) . In addition, clinical studies have revealed that Ecadherin function is lost during the development of most human epithelial cancers, and that deletion or mutation of this gene predisposes to the development of malignant cancer (Tlsty, 1998) .
In this work we describe the ability of HBx to disrupt cell ± cell adhesion. Cadherin and b-catenin mislocalize from adherens junctions, and are redistributed to the detergent-soluble fraction of HBxexpressing cells. The cadherin-cytoskeleton complexes are dissociated and b-catenin appears to be tyrosine phosphorylated in the presence of this viral protein.
We found that HBx-induced adherens junction disruption is dependent on src tyrosine kinase activity. These results provide a new mechanism by which HBx may contribute to HCC development and metastasis.
Results

HBx induces adherens junction disruption
It has been described that loss of cadherin expression or function itself results in the acquisition of a migratory phenotype by epithelial cells, resembling an epithelial to mesenchymal transition (Perl et al., 1998) . Thus, we studied whether HBx was able to modify the integrity of adherens junctions. The pattern of distribution of cadherin and b-and g-catenins was explored in Chang-and HeLa-derived HBx stable transfectants and control cells by immuno¯uorescence analysis. These cells express HBx in a dexamethasoneinducible manner, although a low expression of HBx mRNA is also detectable in the absence of any stimulus ( Figure 1a) . No sign of apoptosis after the induction of HBx expression was observed in these cells (data not shown). CMO cells, either stimulated or not with dexamethasone, and unstimulated CMX cells presented well-conformed adherens junctions, with strong cadherin staining at the intercellular contacts (Figure 1b) . On the other hand, when HBx expression was induced in CMX cells by adding 1 mM dexamethasone, intercellular contacts were broken, and only a diuse staining of cadherins was observed. The same pattern of cadherin distribution was found in HBxexpressing HeLa cells (Figure 1c ), indicating that disruption of adherens junctions was not restricted to a single cell type. The distribution of b-and g-catenins showed a similar immunostaining pattern as cadherin molecules (data not shown).
Alterations in cadherin-based cell ± cell interactions could be due to either loss of cadherin expression or misregulation of its function. Immunoblotting of cell lysates revealed comparable levels of both cadherin and b-catenin in control and HBx-transfected cells ( Figure  1d ), suggesting that disruption of adherens junctions was due to a loss of function rather than to a loss of expression of these molecules.
To further con®rm the eect of HBx on adherens junctions, we studied the distribution of cadherin in the 3pX and 4pX stable transfectants, derived from the murine hepatocytic cell line AML12, which express HBx in a tetracyclin-repressible manner (Tarn et al., 1999) . The 3pX clone shows the features of a transformed dierentiated hepatocyte, with low HBx expression, whereas the 4pX clone displays a more dedierentiated phenotype and higher expression of HBx (Tarn et al., 1999) . In the absence of tetracyclin, Figure 2 Adherens junctions are disrupted in the 4pX but not in the 3pX AML12-derived clone after HBx expression. AML12 3pX and 4pX clones were grown on collagen precoated slides in the presence or absence of 50 mg/ml tetracyclin and subjected to immuno¯uorescence using an anti-pan-cadherin mAb. Bar, 10 mm 4pX cells showed adherens junction disruption and a more diuse cadherin staining pattern when compared with 4pX cells in which HBx expression was still repressed (+ Tet). No signi®cant dierences in adherens junction stability were observed in the 3pX clone, regardless of the presence or absence of tetracyclin (Figure 2 ). Neither the expression of cadherin or b-catenin was aected by the presence of HBx in these cells (data not shown). These results support the idea that HBx is mediating adherens junction disruption, and suggest that the dierentiation status of the cell and/or the level of expression of HBx may be important for its pro-metastatic eect in these cells. Bands were quanti®ed using the Multi-analist software. Dexamethasone-stimulated cells are represented by ®lled bars, whereas empty bars were used for unstimulated cells
HBx triggers the dissociation of the cadherin-cytoskeleton complexes
We next analysed the interaction of the actin cytoskeleton with the cadherin and b-catenin complexes in the presence of HBx. Monolayers of Changand HeLa-derived clones were extracted under mild detergent conditions, enough to solubilize cytoskeletonunbound molecules, as indicated by the presence of all the c-Met receptor in the soluble fraction of both cell lines (Figure 3) . Western blot analysis and subsequent quanti®cation showed a clear increase in the amount of soluble cadherin and b-catenin in CMX and HMX cells stimulated with dexamethasone when compared with unstimulated cells, whereas dexamethasone stimulation had no eect on the control CMO and HMO cells (Figure 3a,b) . Consequently, the levels of insoluble cadherin and b-catenin tend to decrease in the presence of HBx. This eect was more easily detectable in HeLa than in Chang-derived clones (Figure 3a,b) . It is interesting to note that, unlike Chang clones, HeLa clones presented most of their cadherin and catenin molecules in the soluble fraction (our unpublished data). Thus, it is likely that dierences in the insoluble fraction are detected better in HeLa clones due to their lower concentration of these proteins. Immunoblotting with an anti-a-tubulin mAb or anti-c-Met pAb were employed for loading control of the insoluble or soluble extracts. These results suggest that expression of the HBx protein results in a diminished interaction between adherens junction complexes and the cytoskeleton and help to understand the loss of cadherin function observed in the presence of the viral protein.
To further substantiate that HBx was inducing dissociation of the cadherin/catenin-cytoskeleton complexes, we performed co-immunoprecipitation experiments. Cells were lysed in 1% Triton X-100, which solubilizes the whole cadherin complex, and extracts were immunoprecipitated with either an anti-E-cadherin or an anti-b-catenin mAb. Immunoblotting with an anti-b-actin pAb revealed a 45 KDa band in the CMO, stimulated or not with dexamethasone, and unstimulated CMX lanes of both E-cadherin and b-catenin immunoprecipitates (Figure 4) . However, this band was barely detectable in dexamethasone-stimulated CMX cells, suggesting that the cadherin/catenin-actin cytoskeleton complexes were disrupted in the presence of HBx. The 36 kDa band that was recognized by the anti-b-actin pAb resulted to be unspeci®c, since it did not disappear when cells were treated with HGF, which induces E-cadherin and b-catenin degradation in these cells (Figure 4 and our unpublished data). Equivalent amounts of E-cadherin and b-catenin were found to co-immunoprecipitate with each other, regardless of the presence or absence of HBx, consistent with previous reports describing that bcatenin can still be bound to cadherin in the nonadhesive state, where the cadherin-actin complexes are dissociated (Balsamo et al., 1996; Hazan and Norton, 1998) .
Thus it could be suggested that HBx is interfering with adherens junctions not by altering the expression of cadherin or b-catenin, but rather by inducing the cadherin-cytoskeleton complex dissociation and separation from the actin cytoskeleton.
Disruption of adherens junctions by HBx is dependent on tyrosine phosphorylation
Phosphorylation of b-catenin in tyrosine residues results in the dissociation of cytoskeleton linking proteins from the cadherin-cytoskeleton complex and Figure 4 Cadherin and b-catenin complexes with b-actin are dissociated in the presence of HBx. CMO and CMX cells were stimulated or not with 1 mM dexamethasone and lysed in 1% Triton X-100-containing buer. Extracts were immunoprecipitated using anti-E-cadherin and anti-b-catenin mAbs, separated by SDS ± PAGE and immunoblotted using anti-b-actin, anti-pan-cadherin or anti-b-catenin (indicated by arrowheads). CMO cells treated with 10 ng/ml of HGF, which induces cadherin and b-catenin degradation, were used as internal control of co-immunoprecipitation (left panel) Figure 5 Involvement of src tyrosine kinases in the disruption of adherens junction induced by HBx. (a) CMO and CMX cells were stimulated or not with 1 mm dexamethasone and lysed in 1% Triton X-100-containing buer. Cell extracts were immunoprecipitated with an anti-b-catenin mAb and tyrosine phosphorylation was detected using an anti-phosphotyrosine mAb. b-catenin band is indicated by an arrowhead. (b) Cells were treated or not with 10 mM PP1 or 5 mM PP3 and with 1 mm dexamethasone, and tyrosine phosphorylation was analysed by b-catenin immunoprecipitation followed by Western blotting. (c) CMX cells were treated or not with 1 mM dexamethasone and with 5 mM herbimycin A, 10 mM PP1, 5 mM PP3 or DMSO and subjected to immuno¯uorescence analysis using an anti-pan-cadherin mAb. (d) After treatment with dexamethasone and the dierent protein kinase inhibitors, cells were lysed in 0.1% NP-40-containing buer and analysed by Western blot using anti-pan cadherin, anti-b-catenin mAbs or anti-cMet pAb. (e) CMX cells were transfected with pCMS-src-dm or pCMS and subjected to immuno¯uorescence using an anti-pancadherin mAb (upper panels). Transfected cells are identi®ed by the presence of GFP (lower panels). Bar, 10 mm an increase in the free cytosolic pool of b-catenin. This directly correlates with increased cell migration and loss of epithelial morphology (MuÈ ller et al., 1999; Provost and RimmoÈ , 1999) . On the other hand, HBx induces src activity, a tyrosine kinase known to induce b-catenin phosphorylation and adherens junction breakdown (Klein and Schneider, 1997). Thus, we studied whether HBx-induced adherens junction disruption could be mediated by tyrosine kinases, in particular by src.
Immunoprecipitation of cell lysates with an anti-bcatenin mAb and subsequent analysis with an antiphosphotyrosine mAb revealed a 98 KDa band in the CMX/DX lane, that was almost absent from the other precipitates (Figure 5a ). Treatment of CMX cells with the src inhibitor PP1, but not with its structurally related negative control PP3, prior to stimulation with dexamethasone resulted in a partial inhibition of the phosphorylated b-catenin signal (Figure 5b ), indicating that HBx expression results in b-catenin tyrosine phosphorylation, mediated, at least in part, by tyrosine kinases of the src family. Two bands of 50 and 25 kDa were also detected that may correspond to the heavy and light chains of the primary antibody. Immuno¯uorescence analysis showed that the broad range tyrosine kinase inhibitor herbimycin A almost completely prevented the eects of HBx expression on intercellular adhesion ( Figure  5c ). Moreover, the soluble levels of both cadherin and b-catenin in dexamethasone-induced CMX cells treated with this inhibitor decreased to those exhibited by the unstimulated cells (Figure 5d ), whereas DMSO alone had no eect. To further investigate the involvement of tyrosine kinases in HBx-induced intercellular adhesion breakdown, the cells were treated with the src inhibitor PP1 or its negative control PP3. As observed in immuno¯uorescence and Western blot experiments, PP1 prevented almost completely both the adherens junction disruption and the cadherin/b-catenin solubilization triggered by HBx in dexamethasone-induced CMX cells, whereas incubation with PP3 showed no eect (Figure 5c,d) . These results indicated that the eect that HBx expression had on adherens junction stability was mediated by tyrosine kinases, presumably by those of the src family.
To con®rm directly the involvement of src tyrosine kinases in HBx-induced adherens junction disruption, CMX cells were transfected with vectors bearing the GFP gene alone or with a dominant negative form of the src gene, and treated with 1 mM dexamethasone. Whereas transfection of the empty vector had no eect on the HBx-induced disruption of adherens junctions (Figure 5e ), expression of the dominant negative mutant form of src prevented the HBx-triggered eect in the transfected cells. This eect was not observed when a dominant positive mutant src gene was transfected (data not shown). Taken together, these data strongly suggest that the deregulation of intercellular adhesion observed in the presence of HBx is mediated by proteins of the src family.
Discussion
The mechanisms leading to malignant transformation in chronic HBV infection are not well de®ned, and both viral and host factors have been implicated in the process (Chisari, 2000) . Although HBx expression is often detected in HBV-related HCCs (Feitelson and Duan, 1997) , the prognosis and/or prevalence of metastasis of HBx-expressing tumors has not been studied so far. In addition, it has been shown that the X gene is often mutated in HCCs Baptista et al., 1999; Poussin et al., 1999) . However, these mutations accumulate preferently within the transactivation domains of HBx, without aecting HBx-mediated cell transformation (Gottlob et al., 1998b) . Thus it seemed interesting to study the possible role of this viral protein in the late steps of tumor progression.
Changes in cell adhesion are thought to be the basis for tumor cell motility and invasiveness (Tlsty, 1998) . In this regard, the expression or function of the cadherin-catenin complexes has been shown to be impaired in HCC and HCC-derived cell lines. Cadherin and a-catenin expression is frequently reduced in HCCs, correlating with tumor size, low grade of dierentiation and capsular and vascular invasion (Kozyraki et al., 1996) . Deletion of the E-cadherin gene has been shown in HBV-positive HCCs (Slagle et al., 1993; Zondervan et al., 2000) and somatic mutations have been detected in the b-catenin gene in human HCCs and myc or ras transgenic mice (de La Coste et al., 1998; Nhieu et al., 1999) . While it has been thoroughly described that loss of adhesion contributes to the progression of epithelial cells to metastasis, recent data also suggest that loss of adhesion may be involved in the early steps of tumor formation (Perl et al., 1998; Tlsty, 1998) . Misregulation of cadherin function induces early invasion and metastasis in vivo (Perl et al., 1998) , and reversion from an invasive to a non-invasive phenotype can be achieved by exogenous expression of E-cadherin (Vleminckx et al., 1991) , suggesting that E-cadherin might act as a tumor suppressor gene (Christofori and Semb, 1999) . Therefore, loss of adhesion can be considered as a ratelimiting step in the progression from adenoma to carcinoma. In this context, we describe herein the ability of HBx to alter cadherin-based intercellular adhesion in a src-dependent manner. Our results are in agreement with previous reports showing that transfection of the v-src oncogene or treatment with growth factors, which activate endogenous src activity, cause adherens junction disruption and cell migration, and that inhibition of protein tyrosine phosphatases enhances this destabilizing eect (Balsamo et al., 1996; Behrens et al., 1993; Hazan and Norton, 1998; Provost and RimmoÈ , 1999) . In addition, it has been shown that src is activated in tumor tissues of patients with HCC (Masaki et al., 1998) .
The results presented herein, together with our previous ®ndings showing that HBx induces cell migration and interferes with cell ± matrix interactions (Lara-Pezzi et al., 2001a,b) , suggest that, by deregulating intercellular adhesion, HBx might be inducing cellular changes that lead to the acquisition of metastatic properties by tumor cells, and provide a new view of the role played by HBx in tumor cell biology.
Materials and methods
Cells, reagents and antibodies
CMX and CMO clones, derived from the Chang liver cell line (ATCC CCL13), express HBx and CAT proteins in a glucocorticoid-inducible manner. HBx expression was con®rmed by RT ± PCR as described elsewhere (Lara-Pezzi et al., 2001a) . The hepatocyte origin of CMX and CMO clones was con®rmed by their ability to express albumin, a-fetoprotein and the liver alkaline phosphatase (our unpublished data and LuduenÄ a et al., 1976) . HMX and HMO clones are HeLa derivatives, also generated using pMMTV-X and pMMTV-CAT plasmids. The expression of HBx in CMX and HMX cells was induced by treatment with 1 mM dexamethasone (Sigma, St. Louis, MO, USA) for 16 h. Three dierent clones of each cell type were used to avoid clone-speci®c results. AML12-3pX and -4pX derive from the murine hepatic cell line AML12 and express HBx in a tetracyclin-repressible manner (Tarn et al., 1999) .
The tyrosine kinase inhibitors herbimycin A and PP3 were purchased from Calbiochem (San Diego, CA, USA), and the src family inhibitor PP1 was from Alexis (San Diego, CA, USA). Anti-E-cadherin mAb was purchased from Calbiochem. Anti-pan-cadherin, recognizing the cytoplasmic domain common to all cadherins, and anti-a-tubulin mAbs were purchased from Sigma. Anti-b-catenin mAb was obtained from Transduction Laboratories (Lexington, KY, USA), anti-b-actin from Sigma, and anti-c-Met pAb was purchased from Santa Cruz (Santa Cruz, CA, USA). Cy3-labeled goat anti-mouse IgG was from Jackson (West Grove, PA, USA), HRP-conjugated rabbit anti-mouse IgG from Pierce (Rockford, IL, USA) and HRP-conjugated goat anti-rabbit IgG from Amersham (Little Chalfont, UK).
Immunofluorescence
Stable Chang, HeLa and AML12 transfectants were seeded on untreated (Chang and HeLa) or collagen-coated (AML12) slides at a density of 8610 4 or 1.5610 5 cells/well, and 30 h later, the expression of HBx was induced by adding 1 mM dexamethasone (Chang and HeLa) or by removing tetracyclin (AML12). Where indicated, 5 mM herbimycin A, 10 mM PP1, 5 mM PP3 or 0.1% DMSO were added. After 16 h, cells were washed and ®xed in the presence of 1 mM CaCl 2 and MgCl 2 . Cells were then permeabilized with 0.1% NP-40 TBS and incubated with anti-pan-cadherin mAb (1 : 1000). Cy3-labeled goat anti-mouse antibody was added at a 1 : 4000 dilution, and the samples were mounted using mowiol.
Soluble fraction extraction and Western blot
The soluble protein was extracted using CMN buer (50 mM Tris, pH 7.4, 150 mM NaCl, 1 mM CaCl 2 , 1 mM MgCl 2 , 0.1% NP-40, 1 mM PMSF, 20 mg/ml aprotinin, 20 mg/ml leupeptin). 1.5610 5 CMX and CMO cells or 2.5610 5 HMX and HMO were grown in 35 mm plates for 30 h and, where indicated, 1 mM dexamethasone, 5 mM herbimycin A, 10 mM PP1, 5 mM PP3 or 0.1% DMSO were added for 16 h. Cells were washed twice in PBS plus 1 mM CaCl 2 -MgCl 2 , lysed in 300 ml of CMN buer, and the extracts were centrifugated at 12 000 g for 20 min at 48C. Three hundred ml of 26 Laemmli buer were added to the supernatant, and the pellet was resuspended in 600 ml of 16 Laemmli buer. Equal amounts of protein were subjected to Western blot analysis using a 1 : 1500 dilution of anti-pan-cadherin or a 1 : 500 dilution of anti-b-catenin. Anti-a-tubulin and anti-cMet were used at 1 : 2000 and 1 : 50, respectively. For total protein analysis, cells were directly lysed in 16 Laemmli buer and subjected to Western blot. Bands were quantitated using the Multi-analist software (Bio-Rad).
Immunoprecipitations
Cells were lysed in HNTG buer (50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM CaCl 2 , 1 mM MgCl 2 , 1% Triton X-100, 10% glycerol, 100 mM NaF, 2 mM sodium orthovanadate, 0.2 mM sodium molibdate, 20 mM sodium pyrophosphate, 2 mM PMSF, 20 mg/ml aprotinin, 20 mg/ml leupeptin), and lysates were centrifuged at 12 000 g for 20 min at 48C. A total of 350 mg of protein from the supernatants was diluted 1 : 1 with washing buer (20 mM HEPES pH 7.5, 150 mM NaCl, 1 mM CaCl 2 , 1 mM MgCl 2 , 0.1% Triton X-100, 10% glycerol, 10 mM NaF, 2 mM sodium orthovanadate, 0.2 mM sodium molibdate, 10 mM sodium pyrophosphate, 1 mM PMSF, 20 mg/ml aprotinin, 20 mg/ml leupeptin) and precleared with protein G-coupled sepharose. For tyrosine phosphorylation detection, 3 ± 5 mg of protein were used. Thirty ml of 50% (v/v) protein G-coupled sepharose were incubated with goat anti-mouse Ig (30 mg/ml) for 20 min at room temperature, washed and incubated another 20 min with anti-E-cadherin or anti-b-catenin mAbs (5 mg/ml). The antibody-sepharose complexes were added to the precleared lysates and incubated at 48C for 2 h. Immunoprecipitates were resuspended in 30 ml of 26 Laemmli buer and analysed by Western blot.
Plasmids and transfections
pCMS-src-dm, contains a double mutant (A295/F527) of chicken src, that acts as a trans-dominant negative form for all the src family members, under the control of the CMV promoter of the bicistronic vector pCMS (Clontech, Palo Alto, CA, USA) that also drives the expression of GFP under the control of the SV-40 promoter. This construct was generated using the insert of the plasmid pSGT-SrcY527FK, which was generated from the pSGT-srcK-construct using the Transformer site-directed mutagenesis kit (Clontech) and veri®ed by sequencing (Roche et al., 1995 and S Roche, 2001, unpublished results) .
CMX cells, at 50% con¯uency, were transfected with 2 mg of pCMS-derived plasmids using 6 mg of the DOSPER liposomal reagent (Roche, Basel, Switzerland) , according to the manufacturer's instructions. After 24 h, cells were treated for 16 h with 1 mM dexamethasone where indicated, and immunouorescence analysis was carried out as described above.
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